Avectas' Grant

Avectas raised a round of funding on March 20, 2018. Investors include Horizon 2020.

Avectas is a cell engineering technology company, enabling drug developers to manufacture potent engineered cell therapies at therapeutic volumes, with high efficiency and with minimal cell interrupti…

Articles about Avectas' Grant: